Billionaires Are Piling Into a Quantum Computing Stock That Gained Over 3,700% in the Past Year

Leading hedge funds, including Citadel, Tudor Investment, and Two Sigma, significantly increased their positions in quantum computing firm Rigetti Computing (NASDAQ: RGTI) during Q2, following the company's reported advancements in 2-qubit gate fidelity and a $5.8 million Air Force contract. While a B. Riley analyst reiterated a "buy" rating with a $35 price target, the company, despite its stock's substantial recent gains, operates in a highly speculative sector with significant commercialization hurdles, high costs, and a long path to profitability.

Analysis

Rigetti Computing (RGTI) has attracted significant institutional interest, with prominent hedge funds including Citadel, Tudor Investment, and Two Sigma either initiating or substantially increasing their positions during the second quarter. This accumulation follows several positive catalysts, including the achievement of a 99.5% median 2-qubit gate fidelity on its 36-qubit system and a stated timeline to release a 100-qubit system by the end of 2025. Further validation comes from a $5.8 million contract with the Air Force Research Laboratory and a B. Riley analyst's reiterated 'buy' rating with a street-high $35 price target, citing a governmental shift towards commercially viable quantum technology. However, these bullish signals are juxtaposed with considerable fundamental risks. The company's stock has appreciated over 3,700% in the past year, pushing its market capitalization to $9.6 billion despite generating very little revenue and only beginning to approach break-even. The path to large-scale commercialization remains long, expensive, and uncertain, reflecting the overall mixed-to-cautious sentiment surrounding the highly speculative nature of the quantum computing sector.

Key Decisions for Investors

• Given the stock's 3,700% appreciation and speculative fundamentals, investors should treat RGTI as a high-risk position and size any exposure accordingly to account for the potential for significant volatility and sharp sell-offs.
• Monitor key technical and commercial milestones for validation, specifically the company's progress towards its 100-qubit system target by 2025 and the acquisition of further government or enterprise contracts that could de-risk the path to revenue.
• While the Q2 institutional buying is a noteworthy signal, recognize that this data is lagged and does not guarantee sustained interest; upcoming 13F filings should be scrutinized to determine if these hedge funds maintain or increase their conviction.